R&D Spending Is the Most Misleading Number in Business Podcast Por  arte de portada

R&D Spending Is the Most Misleading Number in Business

R&D Spending Is the Most Misleading Number in Business

Escúchala gratis

Ver detalles del espectáculo
Every public company's R&D number is a lie hiding in plain sight. Not because anyone falsified it. Because the number was never built to tell the truth. It was built to satisfy an accounting standard written in 1974. And for fifty years, boards, analysts, and CEOs have been making billion-dollar innovation decisions based on a number designed by accountants to solve a different problem entirely. Here's what makes this genuinely strange. The real number exists. The government has been collecting it from every major US company for decades. It would answer the question every innovation leader and investor actually needs answered. And it is locked away by federal law. Confidential. Never published. Never seen by the people who need it most. It's sitting in a federal database right now. And there's a way to estimate it for any public company, without asking anyone's permission. I know it exists because I spent years building it from the inside. Why the R&D Signal Was Blurry When I was running innovation at HP, we discovered this problem firsthand. We had a connection between R&D investment and gross margin that held up across decades of HP history. Better than anything Wall Street was using. But the signal was blurry. None of us could figure out why. The answer came from a question someone on the team asked almost as an aside. What if R&D isn't one thing? Research and Development Are Not the Same Thing Think about what actually lives inside a typical R&D budget. There's a team somewhere investigating whether a new approach could enable a capability that doesn't exist yet. No product defined. No spec written. Asking whether something is even possible. And there's a team building the next version of a product that ships in eighteen months. Spec locked. Timeline set. Engineering executing against a defined target. Both show up on the same line in the budget. Both get called R&D. Both count equally toward the number that gets reviewed every quarter. They are not the same thing. One is Research. The other is Development. Research is the work you do when you don't yet know what you're building. The output is understanding. New knowledge that might enable future products nobody has designed yet. You can't know exactly what you'll find. If you already knew, it wouldn't be research. Development is the work you do when you know exactly what you're building. The spec exists. The product is defined. The question isn't what to make. It's whether it can be made, on time, at cost, at quality. One creates the future. The other delivers the present. And for fifty years, every public company in America has been required to report them as one indistinguishable number. When we split the HP data along that line, Research on one side and Development on the other, the signal sharpened immediately. Research spend, measured against gross margin three to five years later, was a meaningfully stronger predictor than the combined number had ever been. The blur hadn't been in the gross margin data. It had been in the R&D number itself. Two fundamentally different things, averaged together, producing a number that looked precise and predicted almost nothing. But splitting R from D at the company level was only the beginning. The model was still lying to us. Just more quietly. Why Company-Level R&D Splits Still Mislead Even with the split, something was still soft. HP wasn't one business. It was dozens. Printers, PCs, servers, software, each running on different timelines, different technology cycles, different competitive dynamics. What if the R/D split meant something different depending on where it was applied? We pushed it to the product line level. Then further, to the platform level within product lines. Printers were the clearest example. HP's printer business wasn't one story. There were platforms built on established technology. Mature ink systems, proven print head chemistry, products that had been shipping for years. And there were platforms built on genuinely new core technology. New chemistry. New mechanisms. New approaches to fundamental problems that nobody had solved yet. Research investment by platform told a completely different story than Research investment by product category. The Research going into new technology platforms had a completely different relationship to future margin than Research going into mature platforms. Different time horizons. Different risk profiles. Different margin implications years down the road. Laptops told the same story. A traditional consumer laptop line and a high-performance portable workstation weren't the same investment. One was Development-heavy. Defined product, known market, engineering executing against spec. The other had genuine Research behind it. Unsolved thermal problems, new form factor constraints, and materials questions that hadn't been answered yet. When a single R&D assumption is applied across all of that, treating every dollar the same regardless of what it actually...
Todavía no hay opiniones